Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.02M.
ENTERPRISE VALUE (EV)
$3.02M
Lexaria Bioscience Corp.
Market Cap
$4.83M
Enterprise Value (EV)
$3.02M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $4.83M | $3.02M |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | $1.01M |
| CalciMedica, Inc. (CALC)vs › | $4.85M | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.96M | $8.36M |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | $132258.00 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.14M | $3.57M |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | $4.13M |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | N/A |
| Imunon, Inc. (IMNN)vs › | $5.21M | $6.19M |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.24M | $11.87M |
Market Cap
$4.83M
Total Debt
$0.00
Cash
$1.80M
Enterprise Value
$3.02M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
